Projects

Browse through our collection of selected research projects and discover the diversity of European cooperation in Lower Saxony!

All projects

European Innovation Council funds development of the optical cochlear implant with 2.5 million euros

Scientists from the University Medical Center Göttingen (UMG), OptoGenTech GmbH, which was spun off from the UMG in 2019, the Fraunhofer Institute for Electronic Nano Systems ENAS in Chemnitz, the Finnish company Modulight and the French company SCT Ceramics are receiving 2.5 million euros for the development of the optical cochlear implant to restore hearing in humans. The funds for the three-year “OptoWavePro” project come from the “EIC Transition” funding programme of the European Innovation Council (EIC). The EIC Transition funding specifically supports small and medium-sized companies, start-ups and organisations to transform projects from basic research into marketable products.

Innovative approaches for climate change-adapted grassland management

Farms, and dairy farmers in particular, have a direct influence on biodiversity in grassland ecosystems. Through farm-specific decisions, e.g. when, where, and for how long cows graze on pastures, grazing can have both positive and negative effects on biodiversity. At the same time, climate change requires adapted grassland management, especially on intensive grassland. This is where the DivGrass project comes in. The aim is to make agricultural businesses in grassland management fit for the future against the backdrop of climate change. The central questions are whether species-rich grassland can contribute to greater climate resilience and how adapted grassland management can maintain consistently high production levels and thus the profitability of the farm.

UMG scientist receives highest European award for early career researchers

Prof. Dr Hauke Hillen, head of the “Structure and Function of Molecular Machines” working group at the Institute of Cell Biochemistry at the University Medical Center Göttingen (UMG), independent research group leader at the Max Planck Institute (MPI) for Multidisciplinary Sciences and member of the Cluster of Excellence “Multiscale Bioimaging: From Molecular Machines to Networks of Excitable Cells” (MBExC), will use the funding to investigate how the powerhouses of cells – the mitochondria – produce proteins.

Turning volunteering upside down

Voluntary work is often described as the backbone of our society. However, for today’s youth, it can be challenging and not very appealing to find their place within existing structures of organisations and to work on matters that are close to their personal interests or believes. This is where MIINTER comes into play.

EU project aims to establish optimal therapy for blood cancer

Acute myeloid leukaemia (AML) and chronic lymphocytic leukaemia (CLL) are among the most common forms of blood cancer in adults. Depending on the stage of the disease, patients receive chemotherapy, immunotherapy or a stem cell transplant. The so-called measurable residual disease (MRD) can be used to determine whether the leukaemia is responding very well to the therapy early on in the course of treatment.